Disclosed are methods of inhibiting proliferative diseases characterized by TGF-.beta.-mediated angiogenesis.

Sono rilevati i metodi di inibizione delle malattie proliferative caratterizzate dal angiogenesis del TGF-.beta.-mediated.
 
Web www.patentalert.com

< Covered endoprosthesis and delivery system

< Method of making porous biodegradable polymers

> Compounds and methods for the diagnosis and treatment of ehrlichia infection

> Methods for using 22045, a human cyclic nucleotide phosphodiesterase
~ 00096